(Q36267594)

13 August 2017

1 reference

title

Exogenous reinfection in tuberculosis. (English)

1 reference

13 August 2017

0 references

Chen-Yuan Chiang

1

1 reference

PubMed ID

16183517

13 August 2017

Lee W Riley

series ordinal

2

1 reference

13 August 2017

1 October 2005

1 reference

Lancet Infectious Diseases

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

10

1 reference

13 August 2017

629-636

1 reference

The clinical spectrum of primary tuberculosis in adults. Confusion with reinfection in the pathogenesis of chronic tuberculosis

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Pathogenesis of the Sporadic Case of Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of c

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Patients with active tuberculosis often have different strains in the same sputum specimen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Chemoprophylaxis trial in Canadian Eskimos

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Exogenous reinfection with tuberculosis in a shelter for the homeless.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

IS6110, an IS-like element of Mycobacterium tuberculosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Molecular epidemiology of Mycobacterium tuberculosis in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

DNA fingerprinting of Mycobacterium tuberculosis strains from patients with pulmonary tuberculosis in Honduras

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

RFLP patterns and risk factors for recent tuberculosis transmission among hospitalized tuberculosis patients in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Transmission dynamics of tuberculosis in a high-incidence country: prospective analysis by PCR DNA fingerprinting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Exogenous reinfection in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Recurrent tuberculosis due to exogenous reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

An investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Recurrence in tuberculosis: relapse or reinfection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Simultaneous infection with multiple strains of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

BCG: the challenge continues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970240-1

7 January 2021

10.1016/S1473-3099(05)70240-1

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16183517